McKinsey May 18, 2023
Don Bobo, Joel Portice, Andrew Roth

Two executives behind a cutting-edge healthcare start-up discuss their goal to drastically reduce the number of misdiagnosed and at-risk heart patients through a

Can artificial intelligence and big data be put to work to dramatically improve the treatment of heart disease, the top killer in every developed country? Egnite, a healthcare start-up spun out from California-based medical technology company Edwards Lifesciences, aims to do just that. In this episode of The Venture, McKinsey’s Andrew Roth talks with Joel Portice, president and CEO of egnite, and Don Bobo, corporate vice president at Edwards Lifesciences, to find out how egnite’s digital platform, CardioCare, is harnessing the power of AI and data to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Big Data, Conferences / Podcast, Provider, Technology, Trends
Related Articles:
AI and crypto drove gains in this year's top 5 tech stocks
How To Build An AI Strategy That Works For Your Employees
Visualizing Big Tech Company Spending On AI Data Centers
Design And Technology Industry Pros Predict Top AI Trends For 2025
Looking At Groundbreaking Capabilities With OpenAI O3

Share This Article